These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37844691)
1. Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma. Kim EY; Ruiz ES; Hanna GJ; Thakuria M; Silk AW J Am Acad Dermatol; 2024 Feb; 90(2):427-429. PubMed ID: 37844691 [No Abstract] [Full Text] [Related]
2. The application of circulating tumor DNA in advanced cutaneous squamous cell carcinoma: Potential opportunities and challenges. Sun H; Shen W; Zhong HJ J Am Acad Dermatol; 2024 Aug; 91(2):e31-e32. PubMed ID: 38593973 [No Abstract] [Full Text] [Related]
8. MAGEA3 Expression in Cutaneous Squamous Cell Carcinoma Is Associated with Advanced Tumor Stage and Poor Prognosis. Abikhair M; Roudiani N; Mitsui H; Krueger JG; Pavlick A; Lee J; Therrien JP; Meehan SA; Felsen D; Carucci JA J Invest Dermatol; 2017 Mar; 137(3):775-778. PubMed ID: 27826009 [No Abstract] [Full Text] [Related]
9. A prospective cohort study evaluating m Lazaroff J; Duan GY; Verghese M; Bertacchi B; Yang S; He YY; Bolotin D J Am Acad Dermatol; 2023 Nov; 89(5):1083-1084. PubMed ID: 37516358 [No Abstract] [Full Text] [Related]
10. Circulating tumour DNA for detection of minimal residual disease in head and neck squamous cell carcinoma: A new hope. Jacky Lam WK; Kang G; Winsome Wong WS Ann Oncol; 2023 Dec; 34(12):1080-1081. PubMed ID: 38072511 [No Abstract] [Full Text] [Related]
11. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study. Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709 [TBL] [Abstract][Full Text] [Related]
12. [Histological and clinical prognostic factors in squamous cell carcinoma of the skin. A contribution to the multicenter carcinoma study of the association of surgical and oncological dermatology]. Petter G; Haustein UF Hautarzt; 1999 Jun; 50(6):412-7. PubMed ID: 10427509 [TBL] [Abstract][Full Text] [Related]
13. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
14. Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia. Kleinstern G; Rishi A; Achenbach SJ; Rabe KG; Kay NE; Shanafelt TD; Ding W; Leis JF; Norman AD; Call TG; Cerhan JR; Parikh SA; Baum CL; Slager SL J Am Acad Dermatol; 2020 Dec; 83(6):1581-1589. PubMed ID: 32682027 [TBL] [Abstract][Full Text] [Related]
16. A giant cutaneous squamous cell carcinoma of the neck. Bazine A; Fetohi M Pan Afr Med J; 2018; 30():22. PubMed ID: 30167050 [No Abstract] [Full Text] [Related]
18. Differentiating cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia by multiplex qRT-PCR. Su A; Ra S; Li X; Zhou J; Binder S Mod Pathol; 2013 Nov; 26(11):1433-7. PubMed ID: 23702732 [TBL] [Abstract][Full Text] [Related]